The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience

PURPOSE: to evaluate our experience in terms of local control, survival, adverse effects in patients treated by adjuvant helical tomotherapy (HT) for breast cancer (BC). RESULTS: We studied 179 consecutive patients with 194 treated breasts with adjuvant HT. Median follow-up was 38.1 months. Median a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Arsene-Henry, Alexandre, Foy, Jean-Philippe, Robilliard, Magalie, Xu, Hao-Ping, Bazire, Louis, Peurien, Dominique, Poortmans, Philip, Fourquet, Alain, Kirova, Youlia M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955102/
https://ncbi.nlm.nih.gov/pubmed/29805760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky